Your browser doesn't support javascript.
loading
A 2 kW, 8 GHz-Linewidth Yb-Doped Polarization-Maintained Fiber Laser with Quasi-Flat-Top Pseudo Random Binary Sequence Phase Modulation for SBS Suppression.
Kim, Dong Joon; Koo, Joonhoi; Jun, Seung Won; Jeong, Hwanseong; Lee, Hwihyeong; Lee, Jung Hwan; Jo, Minsik.
Affiliation
  • Kim DJ; Ground Technology Research Institute, Agency for Defense Development, Daejeon 34186, Republic of Korea.
  • Koo J; Ground Technology Research Institute, Agency for Defense Development, Daejeon 34186, Republic of Korea.
  • Jun SW; Ground Technology Research Institute, Agency for Defense Development, Daejeon 34186, Republic of Korea.
  • Jeong H; Ground Technology Research Institute, Agency for Defense Development, Daejeon 34186, Republic of Korea.
  • Lee H; Ground Technology Research Institute, Agency for Defense Development, Daejeon 34186, Republic of Korea.
  • Lee JH; Ground Technology Research Institute, Agency for Defense Development, Daejeon 34186, Republic of Korea.
  • Jo M; Ground Technology Research Institute, Agency for Defense Development, Daejeon 34186, Republic of Korea.
Nanomaterials (Basel) ; 13(8)2023 Apr 10.
Article in En | MEDLINE | ID: mdl-37110914
We demonstrated a narrow-linewidth high-power Yb-doped polarization-maintaining (PM) fiber laser with near-diffraction-limited beam. The laser system consisted of a phase-modulated single-frequency seed source and four-stage amplifiers in the master oscillator power amplifier configuration. A quasi-flat-top pseudo random binary sequence (PRBS) phase-modulated single-frequency laser with a linewidth of 8 GHz was injected into the amplifiers for suppressing stimulated Brillouin scattering. The quasi-flat-top PRBS signal was readily generated from the conventional PRBS signal. The maximum output power was 2.01 kW with polarization extinction ratio (PER) of ~15 dB. The beam quality (M2) was less than 1.3 over the power scaling range.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Nanomaterials (Basel) Year: 2023 Document type: Article Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Nanomaterials (Basel) Year: 2023 Document type: Article Country of publication: Switzerland